L. Liaudet et al., Poly (ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia, SHOCK, 14(2), 2000, pp. 134-141
Citations number
35
Categorie Soggetti
Aneshtesia & Intensive Care","Cardiovascular & Hematology Research
Peroxynitrite-mediated DNA strand breaks trigger poly (ADP-ribose) syntheta
se (PARS) activation, resulting in intracellular energetic failure and orga
n dysfunction, We investigated the role of PARS activation on the inflammat
ory and functional response of the intestine to mesenteric ischemia-reperfu
sion injury. Anesthetized rats exposed to 15 min occlusion of the superior
mesenteric artery showed an increased mucosal PARS activity (ex vivo incorp
oration of radiolabelled NAD(+) in gut mucosal scrapings) as soon as 10 min
after reperfusion. During the first 30 min of reperfusion, significant muc
osal damage developed, as well as mucosal hyperpermeability to a 4000 MW fl
uorescent dextran (FD4). These alterations were significantly reduced by tr
eatment with the NO synthase inhibitor L-NMA, which blocks the production o
f peroxynitrite, as well as with the PARS inhibitors 3-aminobenzamide and n
icotinamide, whereas they were markedly enhanced by the glutathione depleto
r L-buthionine-(S,R)-sulfoximine. Also, PARS inhibition significantly reduc
ed ileal neutrophil infiltration (myeloperoxidase activity) at 3 h reperfus
ion. In a second set of experiments, the effects of 15 or 30 min ischemia f
ollowed by 3 h reperfusion were evaluated in PARS knockout and wild-type mi
ce. Significant protection against histological damage, neutrophil infiltra
tion, and mucosal barrier failure (evaluated by the mucosal-to-serosal FD4
clearance of everted ileal sacs incubated ex vivo) was noted in PARS knocko
ut mice, who also showed reduced alterations in remote organs, as shown by
lesser lipid peroxidation (malondialdehyde formation) and neutrophil infilt
ration in the lung and liver. In conclusion, PARS plays a crucial role in m
ediating intestinal injury and dysfunction in the early and late phases of
mesenteric reperfusion. Pharmacological inhibition of PARS may be a novel a
pproach to protect tissues from reperfusion-related damage.